IL139688A0 - Use of amyloid inhibitors for modulating neuronal cell death - Google Patents

Use of amyloid inhibitors for modulating neuronal cell death

Info

Publication number
IL139688A0
IL139688A0 IL13968899A IL13968899A IL139688A0 IL 139688 A0 IL139688 A0 IL 139688A0 IL 13968899 A IL13968899 A IL 13968899A IL 13968899 A IL13968899 A IL 13968899A IL 139688 A0 IL139688 A0 IL 139688A0
Authority
IL
Israel
Prior art keywords
cell death
neuronal cell
modulating neuronal
amyloid inhibitors
amyloid
Prior art date
Application number
IL13968899A
Original Assignee
Neurochem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurochem Inc filed Critical Neurochem Inc
Publication of IL139688A0 publication Critical patent/IL139688A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL13968899A 1998-05-15 1999-05-14 Use of amyloid inhibitors for modulating neuronal cell death IL139688A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8557198P 1998-05-15 1998-05-15
PCT/IB1999/000968 WO1999059571A1 (en) 1998-05-15 1999-05-14 Use of amyloid inhibitors for modulating neuronal cell death

Publications (1)

Publication Number Publication Date
IL139688A0 true IL139688A0 (en) 2002-02-10

Family

ID=22192515

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13968899A IL139688A0 (en) 1998-05-15 1999-05-14 Use of amyloid inhibitors for modulating neuronal cell death

Country Status (7)

Country Link
EP (1) EP1077690A1 (en)
JP (1) JP2002515429A (en)
AU (1) AU3726299A (en)
CA (1) CA2333203A1 (en)
IL (1) IL139688A0 (en)
MX (1) MXPA00011213A (en)
WO (1) WO1999059571A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1609467A1 (en) * 1998-07-28 2005-12-28 Neurochem (International) Limited Compositions for treating diseases associated with glycosaminoglycan-associated molecular interactions
MXPA02006196A (en) * 1999-12-23 2002-12-09 Neurochem Inc Compounds and methods for modulating cerebral amyloid angiopathy.
AU2003292936A1 (en) * 2002-12-24 2004-07-22 Neurochem (International) Limited Therapeutic formulations for the treatment of beta-amyloid related diseases
DE10303974A1 (en) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid β (1-42) oligomers, process for their preparation and their use
WO2005000406A2 (en) * 2003-06-23 2005-01-06 Neurochem (International) Limited Treatment of amyloid- and epileptogenesis-associated diseases
US20050142191A1 (en) * 2003-06-23 2005-06-30 Neurochem (International) Limited Pharmaceutical formulations of amyloid inhibiting compounds
KR101439828B1 (en) 2005-11-30 2014-09-17 애브비 인코포레이티드 Monoclonal antibodies against amyloid beta protein and uses thereof
KR20080090408A (en) 2005-11-30 2008-10-08 아보트 러보러터리즈 Anti-abeta; globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies
JP5607930B2 (en) 2006-10-12 2014-10-15 ビーエイチアイ リミテッド パートナーシップ Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US20100204230A1 (en) 2007-02-12 2010-08-12 Peter Blurton Piperazine derivatives for treatment of ad and related conditions
US8895004B2 (en) 2007-02-27 2014-11-25 AbbVie Deutschland GmbH & Co. KG Method for the treatment of amyloidoses
US8613923B2 (en) 2007-06-12 2013-12-24 Ac Immune S.A. Monoclonal antibody
US8048420B2 (en) 2007-06-12 2011-11-01 Ac Immune S.A. Monoclonal antibody
PT2238166E (en) 2007-10-05 2014-02-11 Genentech Inc Use of anti-amyloid beta antibody in ocular diseases
WO2011130377A2 (en) 2010-04-15 2011-10-20 Abbott Laboratories Amyloid-beta binding proteins
RU2607368C2 (en) 2010-07-30 2017-01-10 Ац Иммуне С.А. Safe and functional humanized antibodies
CN103298833B (en) 2010-08-14 2015-12-16 Abbvie公司 Amyloid beta associated proteins
GB201315321D0 (en) * 2013-08-28 2013-10-09 Koninklijke Nederlandse Akademie Van Wetenschappen Transduction Buffer
WO2023212289A1 (en) 2022-04-28 2023-11-02 Alzheon, Inc. Tramiprosate for treating apoe4-related diseases
WO2024119183A1 (en) 2022-12-02 2024-06-06 Alzheon, Inc. Methods for treating neurodegenerative disorders with tramiprosate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840294A (en) * 1993-03-29 1998-11-24 Queen's University At Kingston Method for treating amyloidosis
ES2251935T3 (en) * 1993-03-29 2006-05-16 Queen's University At Kingston PROPAN-1,3-DISULPHONIC ACID AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE TREATMENT OF AMYLOIDOSIS.
JP2001515039A (en) * 1997-08-18 2001-09-18 クイーンズ ユニバーシティ アット キングストン Phosphono-carboxylate compounds for treating amyloidosis
MXPA00007815A (en) * 1998-02-11 2002-04-24 Neurochem Inc Method for modulating macrophage activation.

Also Published As

Publication number Publication date
MXPA00011213A (en) 2003-04-22
WO1999059571A1 (en) 1999-11-25
AU3726299A (en) 1999-12-06
CA2333203A1 (en) 1999-11-25
JP2002515429A (en) 2002-05-28
EP1077690A1 (en) 2001-02-28

Similar Documents

Publication Publication Date Title
IL139688A0 (en) Use of amyloid inhibitors for modulating neuronal cell death
IL128662A0 (en) Heterocyclic metalloprotease inhibitors
IL128664A0 (en) Heterocyclic metalloprotease inhibitors
IL137540A0 (en) Inhibitors of phospholipase a2
IL128080A0 (en) Thiol sulfonamide metalloprotease inhibitors
EP0794789A4 (en) Inhibitors of prenyl transferases
PL340727A1 (en) Benzothiazolic inhibitors of proteinous thyrosinic kinase
ZA959948B (en) Matrix metalloprotease inhibitors
PL334846A1 (en) Sulphamidic inhibitors of metaloproteases
IL130851A0 (en) Heterocyclic compounds and their use for inhibiting beta-amyloid peptide
PL343529A1 (en) Substituted pyrrolidine hydroxamate metalloprotease inhibitors
AU2548699A (en) Cell death inhibitors
HUP0101300A3 (en) Matrix metalloprotease inhibitors
NO20012832D0 (en) Heterocyclic carboxamide-containing thiourea inhibitors of herpesvirus containing phenylenediamine group
AU2003203927A1 (en) Use of amyloid inhibitors for modulating neuronal cell death
AU1103699A (en) Use of an inhibitor of the dephosphorylation of darpp-32 for treating schizophrenia
EP0782446A4 (en) Methods of inhibiting endometrial mitoses
HK1048268A1 (en) Neuronal death inhibitors
GB9821614D0 (en) Plug seal for threaded closure
AU1511100A (en) Methods for identifying modulators of neuronal growth
AU2001286744A1 (en) Compounds and methods for inhibiting neuronal cell death
IL131436A (en) Compositions for treatment of disorders involving programmed cell death
IL116731A0 (en) Inhibitors of prenyl transferases
GB9826992D0 (en) Inhibitors
GB9828697D0 (en) Inhibitors